Council

Precision Oncology & Molecular Tumor Board

A molecular-focused expert review where genomic findings are translated into targeted treatment decisions.

This page currently uses template content. It will be updated once the final text is provided.

What is a molecular tumor board?

A molecular tumor board is a dedicated review in which medical oncology, pathology, genetics and bioinformatics experts interpret your genomic test results together.

The aim is to distinguish, among the many variants listed in a report, those that are clinically meaningful and can actually guide treatment.

When does it come into play?

When standard treatment options are exhausted or have not produced a response
When comprehensive genomic testing (large panel / whole exome) has been performed
In rare tumors and cancers of unknown primary
When eligibility for targeted therapy or immunotherapy is being explored
When hereditary cancer risk is suspected

Files requested

The complete genomic / molecular test report, including the variant list
Pathology report and, if possible, tumor block details
Current imaging reports
A summary of treatments received and responses observed

Board output

Prioritization of variants with clinical significance
Approved targeted therapy options, if any
Off-label options presented with their level of evidence
Clinical trial recommendations matching the molecular profile

You are not alone in your cancer treatment journey!

Knowledge, support and trust — with you at every step. Submit your case to our multidisciplinary council today.

Submit My Case